Why some breast cancer express more THRα-2 is not known, but Charalampoudis et al. [28] found that the combined expression of THRα-1 and 2 was lower in invasive ductal breast carcinoma compared to normal breast epithelium, suggesting a loss of expression along with malignant transformation. The gene discussed is THRA; the disease is breast carcinoma.